TG Therapeutics, Inc. (TGTX) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $10.65, up from yesterday’s close by 15.76%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.Fundamental Analysis
TG Therapeutics, Inc. (TGTX) currently trades with a market capitalization of $731.76 Million. That value represents a market adjusting for revenues that have been growing by 0.00 % on a quarterly year/year basis as of the company’s last quarterly report.
You can get a sense of how sustainable that is by a levered free cash flow of -$88.96 Million over the past twelve months. Generally speaking, earnings are expected to grow in coming quarters. Analysts are forecasting earnings of -$0.44 on a per share basis this quarter. Perhaps, that suggests something about why 26.78% of the outstanding share supply is held by institutional investors.
No analysis is ever complete without a thorough survey of a stock’s technical behavior. Looking at the stock’s movement on the chart, TG Therapeutics, Inc. recorded a 52-week high of $15.35. It is now trading 4.7% off that level. The stock is trading $8.30 its 50-day moving average by -2.35%. The stock carved out a 52-week low down at $4.10.
In recent action, TG Therapeutics, Inc. (TGTX) has made a move of +32.30% over the past month, which has come on Strong relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 21.04, and it’s gotten there by action that has been more volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 29.94% with $56.58 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of TGTX.